We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tenet Healthcare (THC) Exceeds Market Returns: Some Facts to Consider
Read MoreHide Full Article
Tenet Healthcare (THC - Free Report) ended the recent trading session at $190.28, demonstrating a +1.12% change from the preceding day's closing price. The stock exceeded the S&P 500, which registered a gain of 0.44% for the day. Meanwhile, the Dow gained 0.36%, and the Nasdaq, a tech-heavy index, added 0.54%.
The hospital operator's stock has dropped by 20.59% in the past month, falling short of the Medical sector's loss of 4.11% and the S&P 500's loss of 3.31%.
The investment community will be paying close attention to the earnings performance of Tenet Healthcare in its upcoming release. The company is slated to reveal its earnings on April 30, 2026. The company's earnings per share (EPS) are projected to be $4.19, reflecting a 3.9% decrease from the same quarter last year. Simultaneously, our latest consensus estimate expects the revenue to be $5.39 billion, showing a 3.15% escalation compared to the year-ago quarter.
For the full year, the Zacks Consensus Estimates project earnings of $17.3 per share and a revenue of $21.99 billion, demonstrating changes of +3.1% and +3.21%, respectively, from the preceding year.
It is also important to note the recent changes to analyst estimates for Tenet Healthcare. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, there's been a 2.37% rise in the Zacks Consensus EPS estimate. At present, Tenet Healthcare boasts a Zacks Rank of #3 (Hold).
Looking at valuation, Tenet Healthcare is presently trading at a Forward P/E ratio of 10.88. For comparison, its industry has an average Forward P/E of 10.88, which means Tenet Healthcare is trading at no noticeable deviation to the group.
Also, we should mention that THC has a PEG ratio of 0.91. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Medical - Hospital industry had an average PEG ratio of 0.91 as trading concluded yesterday.
The Medical - Hospital industry is part of the Medical sector. This group has a Zacks Industry Rank of 54, putting it in the top 23% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Tenet Healthcare (THC) Exceeds Market Returns: Some Facts to Consider
Tenet Healthcare (THC - Free Report) ended the recent trading session at $190.28, demonstrating a +1.12% change from the preceding day's closing price. The stock exceeded the S&P 500, which registered a gain of 0.44% for the day. Meanwhile, the Dow gained 0.36%, and the Nasdaq, a tech-heavy index, added 0.54%.
The hospital operator's stock has dropped by 20.59% in the past month, falling short of the Medical sector's loss of 4.11% and the S&P 500's loss of 3.31%.
The investment community will be paying close attention to the earnings performance of Tenet Healthcare in its upcoming release. The company is slated to reveal its earnings on April 30, 2026. The company's earnings per share (EPS) are projected to be $4.19, reflecting a 3.9% decrease from the same quarter last year. Simultaneously, our latest consensus estimate expects the revenue to be $5.39 billion, showing a 3.15% escalation compared to the year-ago quarter.
For the full year, the Zacks Consensus Estimates project earnings of $17.3 per share and a revenue of $21.99 billion, demonstrating changes of +3.1% and +3.21%, respectively, from the preceding year.
It is also important to note the recent changes to analyst estimates for Tenet Healthcare. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, there's been a 2.37% rise in the Zacks Consensus EPS estimate. At present, Tenet Healthcare boasts a Zacks Rank of #3 (Hold).
Looking at valuation, Tenet Healthcare is presently trading at a Forward P/E ratio of 10.88. For comparison, its industry has an average Forward P/E of 10.88, which means Tenet Healthcare is trading at no noticeable deviation to the group.
Also, we should mention that THC has a PEG ratio of 0.91. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Medical - Hospital industry had an average PEG ratio of 0.91 as trading concluded yesterday.
The Medical - Hospital industry is part of the Medical sector. This group has a Zacks Industry Rank of 54, putting it in the top 23% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.